301122.SZ
采纳股份
SZSE · Healthcare · C 制造业 · CN
CNY 39.00
−1.27%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 425.3M | 356.7M | 387.9M | 410.5M | 465.5M |
| Cost of Revenue | 330.3M | 276.9M | 243.1M | 250.9M | 275.6M |
| Gross Profit | 95.0M | 79.8M | 144.8M | 159.6M | 189.9M |
| Operating Expenses | |||||
| R&D Expense | 25.1M | 22.0M | 26.4M | 21.4M | 19.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 43.4M | 42.5M | 35.5M | 27.9M | 27.4M |
| Selling & Marketing Expense | 11.9M | 9.0M | 11.3M | 6.7M | 4.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 91.6M | 79.4M | 67.0M | 51.2M | 27.7M |
| Cost and Expenses | 422.0M | 356.3M | 310.1M | 302.1M | 303.4M |
| Operating Income (EBIT) | 5.5M | 2.0M | 57.5M | 129.5M | 179.9M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 5.1M | 1.3M | 57.3M | 130.2M | 183.6M |
| Income Tax Expense | (1.5M) | (1.2M) | 4.9M | 17.6M | 21.7M |
| Bottom Line | |||||
| Net Income | 11.0M | 5.6M | 53.1M | 112.6M | 161.9M |
| Earnings from Cont. Ops | 6.6M | 2.6M | 52.3M | 112.6M | 161.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 11.0M | 5.6M | 53.1M | 112.6M | 161.9M |
| Per Share | |||||
| Basic EPS | CN¥0.09 | CN¥0.05 | CN¥0.43 | CN¥0.92 | CN¥1.76 |
| Diluted EPS | CN¥0.09 | CN¥0.05 | CN¥0.43 | CN¥0.92 | CN¥1.76 |
| Revenue Per Share | CN¥3.57 | CN¥3.17 | CN¥3.14 | CN¥3.35 | CN¥5.06 |
| Shares | |||||
| Basic Shares Outstanding | 119.2M | 112.4M | 123.5M | 122.4M | 92.0M |
| Diluted Shares Outstanding | 119.2M | 112.4M | 123.5M | 122.4M | 92.0M |
| Profitability Metrics | |||||
| EBITDA | — | 54.3M | 96.2M | 161.3M | 207.6M |
| D&A | — | 52.3M | 38.8M | 31.8M | 27.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026